| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700167 | 重组人源化抗白介素-6受体单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2018-03-28 | 北京伟德杰生物科技有限公司 | BeiJing VDJBio Co Ltd | In Review | 2018-03-27 | view | |
| CXSL2000313 | 注射用重组人CTLA-4-Fc融合蛋白 | Lyophilized | Biological Products(1) | New Drug Application | 2020-11-04 | 北京伟德杰生物科技有限公司 | BeiJing VDJBio Co Ltd | In Review | 2020-11-03 | view |